COMPUTING OF THE RAD51 -BRCA2 INTERACTIONS Assist. Prof. Albena Todorova, PhD Andrey Kirov, Msc Peycho Petkov, PhD Computing of the effects of genetic.

Slides:



Advertisements
Similar presentations
Uses of Genomic Information in the Diagnosis of Disease
Advertisements

Global Mapping of the Yeast Genetic Interaction Network Tong et. al, Science, Feb 2004 Presented by Bowen Cui.
What is Li-Fraumeni syndrome?
Investigating the BRCA1 Mutation F.R.E.S.H Docs. Angelina Jolie Actress, Film director, and Screenwriter Mother had Breast Cancer and died at 56 from.
Type Of Cancer:Location: CarcinomaEpithelial Cells SarcomaConnective Tissue LeukemiaCirculatory / Lymphatic.
Detection of Hereditary Breast Cancer
Most UV lesions are repaired by Nucleotide Excision Repair (NER) Stalled replication forks may be bypassed by alternative (bypass) DNA polymerases (REV1,
DNA marker analysis Mrs. Stewart Medical Interventions Central Magnet School.
BRCA2 Blue: Rad51; Green: BRCA2
Mechanism of Homologous Recombination
BRCA1 The First Breast Cancer Gene Presentation By Liz Mosley.
Genetic Recombination 3 by: Nouf alyami. Content I. INTRODUCTION. II. GENERAL RECOMBINATION III. SITE-SPECIFIC RECOMBINATION.
Introduction Statistics  Worldwide  Arab World Noor Halawa Dr. Samar Musmar.
PCR Application: Can Breast Cancer be Cured?. Normal, Healthy Cells Cells can change or differentiate to become specialised according to the tissue that.
BRCA Genes Dallas Henson.
BRCA Mutations and Breast Cancer Ruth Phillips and Patty Ashby.
The Cancer Pedigree BRCA What?. Outline Introduction: Understanding the weight of genetics in Ovarian Breast Cancer BRCA 1 and BRCA 2 Genes – Function.
DNA Recombination Mechanisms AHMP Objectives List the major classes of mobile genetic elements (we went over this before) Describe the process of.
Gene Mutations.
DNA Repair and Cancer. Genome Instability Science, 26 July 2002, p. 544.
Cancer data and efficient sequencing Ruchik S. Yajnik.
Cancer Estimated US Cancer Cases Cancer Incidence Rates for Women, USA.
BRCA2 Clark Cunningham March 26, 2015 BIOL445 American Cancer Society, eastcancer/make-a-pink-ribbon-lapel-pin,
Angelina Jolie The White Coat Wonder. Rational  The purpose of our research is to enrich the Premed-A community with the knowledge of other cancers caused.
Bloom’s Syndrome and Bloom helicase Alexandra Otto March 16, 2004.
Last lesson we looked at: What is the definition of a gene?
Unknown genetic predisposition in familial breast cancer can lie deep in family tree San Ming Wang University of Nebraska Medical Center.
Breast Cancer By: Christen Scott.
BRCA1 and Breast Cancer Madeline Ryan 3/17/2015.
BRCA1: Tumor Suppression and Breast Cancer A breast cancer cell dividing.
Breast Ovarian Hereditary Breast & Ovarian Cancer Knowing one’s family medical history can be life-saving.
Breast Cancer and BRCA2. 1 million women worldwide diagnosed. 1 out of 12 women in Western Europe and the United States 30% mortality rate Highest cause.
Chapter 13: Chromosome 13 BCCIP mRNA transcription translation Amino acid sequence Name of Protein DNA Sequence Name of Gene Chromosome What does this.
Homologous Recombination
Breast Cancer. Breast cancer is a disease in which malignant cells form in the tissues of the breast – “National Breast Cancer Foundation” The American.
Breast Cancer: BRCA1/2 Erin Hayes Foundations of Medicine Blue Valley CAPS October 28,
BRCA2: Breast Cancer Susceptibility Gene 2 Lindy Behrend March 4, 2003.
How many genes are there?
Natasha Adlakha Bio445. Discovery in Breast Cancer Reverse Genetics BReast CAncer Gene Chromosome 13 Tumor suppressor gene Penetrance Familial,
Tumor Suppressor Gene Involved in Breast and Ovarian Cancers SCIENCE96/gene.cgi?BRCA1.
Breast Cancer Ten percent of breast cancer is hereditary. Or 23,000 women a year with a genetic basis for their cancer. The most common mutations in this.
BLOOM HELICASE (and BLOOM SYNDROME)
By: Anthony, Sophia, Jessica, Terrance, and Sierra.
Genomic Medicine Rebecca Tay Oncology Registrar. What is Genomic Medicine? personalised, precision or stratified medicine.
Homologous Recombination
BREAST CANCER IS A DISEASE OF THE DEVELOPED WORLD POLINA USTYUZHANINA 1 EN 117 LINNEUNIVERSITETET MODULE 3 VT-13.
DNA R ECOMBINATION M ECHANISMS Fahareen Binta Mosharraf MNS 1.
1 Finding disease genes: A challenge for Medicine, Mathematics and Computer Science Andrew Collins, Professor of Genetic Epidemiology and Bioinformatics.
HCDC4 & Endometrial Carcinoma Diana Rhyne. hCDC4 – Gene Information  Homologs in S. cervisiae, Drosophilia, and C. elegans  Tumor Suppressor  Expressed.
Mechanism of Homologous Recombination (HR)
Karyotyping Cancer.
Genetics In Breast Cancer
Family Tree Presentation
 The human genome contains approximately genes.  At any given moment, each of our cells has some combination of these genes turned on & others.
Human Cells Human genomics
breast cancer 2, early onsetpro What does this protein make up or do?
Recombination December 6, 2017.
Breast cancer is the most common cancer among women
DNA damage DNA gets damaged a lot! >200,000 events/human cell/day.
Genomic Instability and Cancer
Recombination May 2, 2018.
Origin of Chromosomal Translocations in Lymphoid Cancer
Volume 137, Issue 2, Pages (May 2015)
Cancer Susceptibility and the Functions of BRCA1 and BRCA2
Volume 7, Issue 2, Pages (February 2001)
Homologous recombination
Specific Tumor Suppressor Genes
Biology of hereditary breast and ovarian cancer (HBOC)
Risk Factors for Male Breast Cancer
Presentation transcript:

COMPUTING OF THE RAD51 -BRCA2 INTERACTIONS Assist. Prof. Albena Todorova, PhD Andrey Kirov, Msc Peycho Petkov, PhD Computing of the effects of genetic mutations in the BRCA2 gene to the protein structure and evaluation of these changes to their interactions with other proteins

WHY? women died in 2004 due to breast cancer, and although breast cancer is thought to be a disease of the developed world, a majority (69%) of all breast cancer deaths occurs in developing countries (WHO Global Burden of Disease, 2004)‏ According to WHO breast cancer is the most common cancer in women worldwide, comprising 16% of all female cancers Breast cancer survival rates vary greatly worldwide, ranging from 80% or over in North America, Sweden and Japan to around 60% in middle-income countries and below 40% in low-income countries (Coleman et al., 2008). The low survival rates in less developed countries can be explained mainly by the lack of early detection and prophylactics programmes

Family history of breast or ovarian cancer - increases the risk by a factor of two or three. Some mutations, particularly in BRCA1 and BRCA2 genes result in a very high risk for breast cancer RISK FACTORS Age – cancer risk increases with aging, no matter of genetic predispositions Hormone influence – high estrogen level increases the risk Obesity Nutrition diete

DNA ISOLATION BRCA GENETIC TESTS ALGORITHM SEQUENCING OF BRCA1 & BRCA2 GENES qPCR/MLPA ANALYSIS OF BRCA1 & BRCA2 GENES NORMAL RESULT EVERYTHING IS OK LARGE DELETIONS/DUPLICATIONS ARE DETECTED INCRESED RISK OF BREAST AND OVARIAN CANCER MUTATION WITH KNOWN GENOTYPE- PHENOTYPE CORRELATION DETECTION OF POINT MUTATIONS MUTATION WITH UNKNOWN GENOTYPE- PHENOTYPE CORRELATION ?

BRCA2 The BRCA2 tumour suppressor is essential for homologous DNA recombination, a process for the errorfree repair of DNA double-stranded breaks, in the cells of higher eukaryotes BRCA2 central function during recombination is to control the RAD51 recombinase, which is indispensable for DNA recombination The homologous DNA recombination begins when broken DNA is end- resected to generate ssDNA, upon which RAD51 oligomerizes to form an active nucleoprotein filament. The RAD51 nucleoprotein filament catalyzes strand exchange by invading and pairing with a homologous DNA duplex, used as a template for repair

Reymera et al., 2009

BRCA2-RAD51 INTERACTIONS Two distinct regions in human BRCA2 bind directly to RAD51: 1.Eight BRC repeats, evolutionarily conserved motifs of approximately 35 residues each, distributed in a 1100 residue region of BRCA2 (BRC1-8) - conserved amongst vertebrate orthologues in both their sequence and spacing 2. C-terminus RAD51-interacting region - stabilizes RAD51 oligomeric assemblies in vitro both on and off DNA

BRCA2-RAD51 INTERACTIONS BRCA2 BRC repeats

SIMULATION OF BRCA2-RAD51 INTERACTIONS PROBLEMS The whole 3D structure of BRCA2 is still unknown, we have information for the 3D structure of region of BRC4 repeat: Aminoacid sequence of BRC4 repeat: PTLLGFHTASGKKVKIAKESLDKVKNLFDEKEQ Position:

Crystal structure of a RAD51-BRCA2 BRC4 repeat complex DOI: /pdb1n0w/pdb Source: RCSB Protein Data Bank

SIMULATION OF BRCA2-RAD51 INTERACTIONS PROBLEMS In this region we have very limited information about the correlation Genotype - Phenotype Solution In this region we have 1 mutation with known correlation Genotype- Phenotype and used it to test our model Computing the interaction of the normal/wild type BRC4 and RAD51 and its use as a base to compare

Mutation № MutationSR-LJCoul-SRSR-Energy 1 Wild type Trp1520Ala Phe1524Val Gly1529Arg Pro1519His Pro1519Lys Leu1521Ser Phe1524Tyr Phe1524Trp Phe1524Gly Phe1546Tyr Phe1546Trp Phe1546Ser Asp1547Tyr SIMULATION OF BRCA2-RAD51 INTERACTIONS Normal Phenotype

CONCLUSION THE STRUCTURAL HOMOLOGY IN THE REGION OF THE TWO HIDROPHOBIC POCKETS IS MORE IMPORTANT FOR THE BRC4- RAD51 COMPLEX STABILITY THAN THE HIDROPHOBIC INTERACTIONS INSIDE THE POCKET

CONTROVERSARY Position: A peptide containing both F1524 and F1546 mutated to tryptophan retains similar behaviour

SO? WHAT TO DO?

MORE RESEARCH

Acknowledgement: Financial support of Bulgarian Supercomputing Centre (BGSC) is greatly appreciated – Grant 10/2009